News
03-02-2017, 07:40 PM
A team of researchers led by Alex Toker of the Ludwig Center at Harvard has discovered a metabolic weakness in triple-negative breast cancer cells that may be exploited to quell their resistance to chemotherapy.
More... (http://www.news-medical.net/news/20170302/Metabolic-vulnerability-in-triple-negative-breast-cancerc2a0cells-may-help-quell-chemotherapy-resistance.aspx)
More... (http://www.news-medical.net/news/20170302/Metabolic-vulnerability-in-triple-negative-breast-cancerc2a0cells-may-help-quell-chemotherapy-resistance.aspx)